News for Argenica Therapeutics Limited (AGN.AX)

Argenica Therapeutics's rat study of its traumatic brain injury drug ARG-007 has shown early-stage evidence of neuroprotective action.

. All eyes are now on the RBA, which meets on Tuesday, with most analysts predicting rates to stay on hold.

Argenica Therapeutics Ltd has received two key designations from the US Food and Drug Administration for its ARG-006 candidate

The ASX200 closed the day in record territory - nearly a per cent up with every sector finishing in the green ahead of the Easter weekend.

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last record set on the 8th of March at 7847 points.

Biotech firm Argenica Therapeutics has initiated dosing for the first stroke patient in its Phase 2 clinical trial of ARG007.

The ASX200 was having its best day in a fortnight as it hit 7829 in mid-morning trade, coming off record highs of 7860 earlier in the month

Argenica Therapeutics announced on Monday the company has won rare pediatric disease designation (RPDD) for its flagship drug ARG-007.

Argenica Therapeutics Limited announced the appointment of Ms. Dianne Angus as Non- Executive Chair, effective 1 December 2023. Ms. Angus brings extensive executive managerial and company director...

Argenica Therapeutics (ASX:AGN) has delivered "encouraging" results from a preclinical study assessing the efficiency of ARG-007 in modTBI.

Is it the Year of the Semis, Guy Le Page isn't deserting gold, and a much better option than miserly term deposits.

The ASX slid into the murkiest of mires this afternoon, down 0.6% and with barely a handful of standouts to make getting out of bed today worthwhile.

The ASX has rolled into lunch down 0.2%, CleanSpace is up 47% for the morning and the Mystery of the Missing Monkeys has finally been solved.

The ASX is set to pull back this morning after falls on Wall Street. Google's AI chatbot Bard delivered a wrong answer

There were 191 ASX IPOs in calendar year 2021, and 15 of them were biotech stocks.But in 2022 there were only 3 biotech listings.

The AusBiotech investment conference kicks off next week in WA and Vida Ventures says venture capital is key for growing Aussie companies.

ASX small caps to watch on Thursday 24 Feb, and highlights from Wall Street overnight. Stocks to watch include Airtasker and Gentrak.

The best IPOs of 2021 on the ASX included Kuniko (ASX:KNI), Argenica Therapeutics (ASX:AGN) and Australian Rare Earths (ASX:AR3)

Investors piled into NEU after its North American research partner, Acadia Pharma (Nasdaq: ACAD) reported positive Phase 3 trial results.